Nalaganje...
CAR T-cell therapy in multiple myeloma: more room for improvement
The emergence of various novel therapies over the last decade has changed the therapeutic landscape for multiple myeloma. While the clinical outcomes have improved significantly, the disease remains incurable, typically in patients with relapsed and refractory disease. Chimeric antigen receptor (CAR...
Shranjeno v:
| izdano v: | Blood Cancer J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085238/ https://ncbi.nlm.nih.gov/pubmed/33927192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00469-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|